Enabling and leading commercialization and industry partnerships for a healthier world, Commercialization at UHN is the research commercialization hub based at the University Health Network in Toronto. We are the catalyst for accelerating UHN’s world-class research discoveries towards maximum patient impact globally.
Technologies discovered, developed and de-risked at UHN form the basis of products and services improving health care for patients internationally, including therapeutics, devices and diagnostics. In many cases, these represent the foundational platforms for a number of successful companies first incubated within UHN.
L to R: Mark Taylor, Director, Commercialization; Dr. Heather Ross, Dr. Joseph Cafazzo, Dr. Brad Wouters, Executive Vice President, Science and Research
Drs. Heather Ross and Joseph A. Cafazzo were named 2022 joint Inventors of the Year for revolutionizing cardiac care through Medly, a digital health solution for heart health care from anywhere. Medly reduces heart failure management costs and hospitalizations by 50% and forms the basis of a new UHN venture, Medly Therapeutics, poised to bring heart care benefits to patients around the world.
View Past WinnersProudly sponsored by Commercialization at UHN, the UHN Inventor of the Year Award recognizes an inventor or team who has made a substantial and noteworthy contribution to developing healthcare innovations with high commercialization potential.
Do you think your medical innovation is a contender?